1998
DOI: 10.1084/jem.188.12.2375
|View full text |Cite
|
Sign up to set email alerts
|

Natural Killer (NK) Cell–mediated Cytotoxicity: Differential Use of  TRAIL and Fas Ligand by Immature and Mature Primary Human NK Cells

Abstract: Mature natural killer (NK) cells use Ca2+-dependent granule exocytosis and release of cytotoxic proteins, Fas ligand (FasL), and membrane-bound or secreted cytokines (tumor necrosis factor [TNF]-α) to induce target cell death. Fas belongs to the TNF receptor family of molecules, containing a conserved intracytoplasmic “death domain” that indirectly activates the caspase enzymatic cascade and ultimately apoptotic mechanisms in numerous cell types. Two additional members of this family, DR4 and DR5, transduce ap… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

7
307
2
5

Year Published

1999
1999
2018
2018

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 458 publications
(322 citation statements)
references
References 38 publications
7
307
2
5
Order By: Relevance
“…Notably, TRAIL is expressed on a variety of cells involved in host defense against viral infection including cytotoxic T cells, 9,10 dendritic cells, 11 monocytes/macrophages 12 and natural killer (NK) cells. 13,14 Not surprisingly, viruses have developed sophisticated strategies to both exploit TRAIL's potent cytotoxic properties, and to modulate cellular responses to TRAIL. For example, infection with human immunodeficiency virus-1 (HIV-1) can trigger the expression of TRAIL in monocytes, contributing to HIV-1 pathogenesis by inducing CD4( þ ) T-cell death.…”
Section: Introductionmentioning
confidence: 99%
“…Notably, TRAIL is expressed on a variety of cells involved in host defense against viral infection including cytotoxic T cells, 9,10 dendritic cells, 11 monocytes/macrophages 12 and natural killer (NK) cells. 13,14 Not surprisingly, viruses have developed sophisticated strategies to both exploit TRAIL's potent cytotoxic properties, and to modulate cellular responses to TRAIL. For example, infection with human immunodeficiency virus-1 (HIV-1) can trigger the expression of TRAIL in monocytes, contributing to HIV-1 pathogenesis by inducing CD4( þ ) T-cell death.…”
Section: Introductionmentioning
confidence: 99%
“…More in general, NK cells can be activated by various stimuli such as contact with dendritic cells (DC), MHC-I-negative cells, binding of IgG immunocomplexes, direct engagement of NKR by stress-induced tumor-associated molecules or pathogen-derived products, and several cytokines such as IL-1, IL-2, IL-12, IL-15, IL-18, IL-21, and type I IFNs (8 -25). Upon cytokine stimulation, NK cells become lymphokine-activated killer (LAK) cells that proliferate, produce cytokines, and upregulate effector molecules such as adhesion molecules, NKp44, perforin, granzymes, Fas ligand (FasL), and TRAIL (8,9,12,(25)(26)(27)(28)(29). Thanks to this new pattern of protein expression, LAK cells enhance their ability to adhere to and recognize target cells, leading to a broader killing activity against tumor cells that essentially takes place as (30): 1) perforin/granzyme-dependent necrosis of target cells, involving cell adhesion, NKR triggering, and granule release (31,32); and 2) apoptosis of target cells, which involves cell adhesion and is mediated by surface TNF ligand family members a) FasL, b) TNF-␣, and c) TRAIL, each of which interacts with specific receptors on the target cell surface (26 -29).…”
mentioning
confidence: 99%
“…Increased incidence of primary tumors and metastases has been described in TRAILdeficient mice (35). However, TRAIL is present in the bone marrow, a site of NK cell as well as erythromyeloid differentiation (29,36). Since it has been demonstrated that erythroid cell differentiation is negatively regulated in vitro and in vivo by recombinant TRAIL (36 -38), its use in therapy should be cautious.…”
mentioning
confidence: 99%
“…Proportion of TRAIL‐positive NK cells significantly increased in LMNC from group B compared with that from group A ( P = 0.03; Figure 2D). Reportedly, TRAIL can induce either apoptosis by Fas‐associated death domain‐dependent mechanism or necrosis through receptor‐interactive peptide‐dependent cascade through the ligation of its death domain‐containing receptors under physiological conditions 28. MFI of NKp46 and CD122, known as IL‐2Rβ, on liver NK cells was significantly higher in group B than in group A ( P = 0.04 and P = 0.03, respectively; Figure 2C).…”
Section: Resultsmentioning
confidence: 96%